These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis. Zhou G; Tsai CW; Liu JO J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1. Akselsen OW; Odlo K; Cheng JJ; Maccari G; Botta M; Hansen TV Bioorg Med Chem; 2012 Jan; 20(1):234-42. PubMed ID: 22137934 [TBL] [Abstract][Full Text] [Related]
9. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo. Lu J; Chong CR; Hu X; Liu JO J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390 [TBL] [Abstract][Full Text] [Related]
11. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties. Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353 [TBL] [Abstract][Full Text] [Related]
12. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2. Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors. Hou YP; Sun J; Pang ZH; Lv PC; Li DD; Yan L; Zhang HJ; Zheng EX; Zhao J; Zhu HL Bioorg Med Chem; 2011 Oct; 19(20):5948-54. PubMed ID: 21925884 [TBL] [Abstract][Full Text] [Related]
14. MetAP-2 inhibitors based on the fumagillin structure. Side-chain modification and ring-substituted analogues. Rodeschini V; Boiteau JG; Van de Weghe P; Tarnus C; Eustache J J Org Chem; 2004 Jan; 69(2):357-73. PubMed ID: 14725448 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors. Peifer C; Selig R; Kinkel K; Ott D; Totzke F; Schächtele C; Heidenreich R; Röcken M; Schollmeyer D; Laufer S J Med Chem; 2008 Jul; 51(13):3814-24. PubMed ID: 18529047 [TBL] [Abstract][Full Text] [Related]
16. Potent triazolyl-proline-based inhibitors of HCV NS3 protease. Naud J; Lemke C; Goudreau N; Beaulieu E; White PD; Llinàs-Brunet M; Forgione P Bioorg Med Chem Lett; 2008 Jun; 18(11):3400-4. PubMed ID: 18448339 [TBL] [Abstract][Full Text] [Related]
17. Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis. Trabocchi A; Menchi G; Cini N; Bianchini F; Raspanti S; Bottoncetti A; Pupi A; Calorini L; Guarna A J Med Chem; 2010 Oct; 53(19):7119-28. PubMed ID: 20809642 [TBL] [Abstract][Full Text] [Related]
18. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A. Czakó B; Kürti L; Mammoto A; Ingber DE; Corey EJ J Am Chem Soc; 2009 Jul; 131(25):9014-9. PubMed ID: 19469509 [TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2). Garrabrant T; Tuman RW; Ludovici D; Tominovich R; Simoneaux RL; Galemmo RA; Johnson DL Angiogenesis; 2004; 7(2):91-6. PubMed ID: 15516829 [TBL] [Abstract][Full Text] [Related]